Low-Glutamate Diet for Migraine Relief
Official title: Diet-Based Treatment for Migraine Relief
Run by American University · NCT07360405 · Data updated 2026-11-12
This study tests whether a low-glutamate diet can reduce migraine days and symptoms in adults with migraine, compared with a wait-list control.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | American University Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | March 2, 2026 |
| Main results expected | December 2026 |
| Study ends | May 2027 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07360405 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-75 with chronic or episodic migraine (8 migraine days per month and 4 migraine days per month, respectively) and a stable medication regimen.
✕Probably not a fit
Individuals not responding to dietary changes or unable to maintain dietary restrictions may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare a low-glutamate diet to a wait-list control in adults with chronic or episodic migraine. After a 4-week run-in to track headaches, eligible participants are randomized to start the low-glutamate diet or continue their usual diet for one month, with outcomes including migraine frequency, severity, duration, and quality of life. The study also examines changes in blood markers related to migraine and, in a subset, potential brain changes. Dietary training is provided to participants in the intervention arm, focusing on avoiding foods high in free glutamate and emphasizing nutrient-rich whole foods. The trial is conducted at American University with collaboration from Georgetown University.
Why it matters
Potential benefit: If successful, participants may experience fewer migraine days and milder attacks, with potential improvements in quality of life.
How similar studies have gone: Prior research suggested migraine improvements with low-glutamate diets and related brain changes, though results vary and further confirmation is needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women of all races and ethnicities * Age 18-75 years * Documented diagnosis of chronic or episodic migraine for at least 6 months, based on International Classification of Headache Disorders, 3rd edition (ICHD-III) criteria, defined as: * 8 headache days per month, and * 4 migraine days per month * Migraine onset before age 50 * On a stable medication regimen for at least 1 month prior to enrollment * Willing to maintain stable medications throughout the study * Willing to discontinue supplements during the study period * Women of childbearing potential must be willing to use birth control during the study timeframe Exclusion Criteria: * Current pregnancy, plans to become pregnant during the study timeframe, or current breastfeeding * Current use of medications affecting glutamatergic or gamma-Aminobutyric Acid (GABA) neurotransmission (unless discontinued under physician guidance) * Current use of quarterly injectable migraine preventive medications * Unwillingness to modify dietary intake or to stop alcohol and marijuana use during the study * Substance use disorder within the past year * Diagnosed seizure disorder * Severe asthma requiring past hospitalization
Where it's running
-
American University
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Study coordinator: Kathleen Holton
- Email: holton@american.edu
- Phone: 5037571578
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Elismetrep (K-304) for acute treatment of migraine
This study tests whether a single dose of elismetrep can quickly lessen the pain of a migraine compared with placebo in adults 18 to 75.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Online Hatha Yoga Add-On for High-Frequency Episodic Migraine
This trial tests whether a 12-week online Hatha yoga program added to usual migraine treatment can help adults with high-frequency episodic migraine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.